Williams Olughu, Ph.D., is a senior principal scientist at Ipsen Biopharmaceuticals Ltd. in the United Kingdom, where he serves as the CMC technical lead for one of the company’s antibody-drug conjugate programs. He is a Royal Academy of Engineering visiting professor at Loughborough University and an editorial board member for the World Journal of Microbiology and Biotechnology and the Journal of Chemical Technology and Biotechnology.